S
Staedtisches Klinikum Karlsruhe | Medizinische Klinik III - Onkologie, Hämatologie, Infektiologie und Palliativmedizin
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Cytarabine
Obinutuzumab
Etoposide
Dabrafenib
Dofetilide
Acalabrutinib
Flecainide
Propafenone
All-Trans Retinoic Acid
Sotalol
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 10 total trials
This multicenter, prospective, open-label, randomized, superiority phase 3 study is designed to demonstrate that treatment with a triple combination...
Enrolling
Chronic Lymphocytic Leukemia
Drug: Venetoclax
Drug: Obinutuzumab
The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with...
Active, not recruiting
Persistent Atrial Fibrillation
Device: FARAPULSE™ Pulsed Field Ablation (PFA) System
Drug: Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone
Trial sponsors
U
E
N
G
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems